Search research articles
Contact Us
Filters
Showing results (11-20 of 251) with videos related to
Page
of 26
Sort By:
Advances in Therapy
|
February 21, 2013
Mechanisms and clinical efficacy of lixisenatide for the management of type 2 diabetes
Michael Horowitz, Christopher K Rayner, Karen L Jones
Alimentary Pharmacology & Therapeutics
|
April 24, 2023
Editorial: empirical pharmacological management of gastroparesis-a cautionary tale
Karen L Jones, Christopher K Rayner, Michael Horowitz
JAMA
|
September 28, 2021
Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy and Body Weight in Adults With Overweight or Obesity
Christopher K Rayner, Karen L Jones, Michael Horowitz
Gastroenterology
|
March 31, 2019
Is Making the Stomach Pump Better the Answer to Gastroparesis?
Christopher K Rayner, Karen L Jones, Michael Horowitz
Journal of Gastroenterology and Hepatology
|
April 28, 2005
Push enteroscopy alters management in a majority of patients with obscure gastrointestinal bleeding
Nam Q Nguyen, Christopher K Rayner, Mark N Schoeman
Vitamins and Hormones
|
November 25, 2010
Dietary effects on incretin hormone secretion
Tongzhi Wu, Christopher K Rayner, Karen Jones, et al.
Drugs
|
August 9, 2007
Pathophysiology and management of diabetic gastropathy: a guide for endocrinologists
Paul Kuo, Christopher K Rayner, Karen L Jones, et al.
Drugs
|
June 6, 2009
Diabetic gastroparesis: diagnosis and management
Jing Ma, Christopher K Rayner, Karen L Jones, et al.
Therapeutics and Clinical Risk Management
|
August 27, 2009
Incretin-based therapies: new treatments for type 2 diabetes in the new millennium
Joan Khoo, Christopher K Rayner, Karen L Jones, et al.
Pharmaceutics
|
August 23, 2020
Enteroendocrine Hormone Secretion and Metabolic Control: Importance of the Region of the Gut Stimulation
Cong Xie, Karen L Jones, Christopher K Rayner, et al.
Page
of 26
Search research articles
Search
Showing results (11-20 of 251) with videos related to
Sort By:
Page
of 26
Advances in Therapy
|
February 21, 2013
Mechanisms and clinical efficacy of lixisenatide for the management of type 2 diabetes
Michael Horowitz, Christopher K Rayner, Karen L Jones
Alimentary Pharmacology & Therapeutics
|
April 24, 2023
Editorial: empirical pharmacological management of gastroparesis-a cautionary tale
Karen L Jones, Christopher K Rayner, Michael Horowitz
JAMA
|
September 28, 2021
Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy and Body Weight in Adults With Overweight or Obesity
Christopher K Rayner, Karen L Jones, Michael Horowitz
Gastroenterology
|
March 31, 2019
Is Making the Stomach Pump Better the Answer to Gastroparesis?
Christopher K Rayner, Karen L Jones, Michael Horowitz
Journal of Gastroenterology and Hepatology
|
April 28, 2005
Push enteroscopy alters management in a majority of patients with obscure gastrointestinal bleeding
Nam Q Nguyen, Christopher K Rayner, Mark N Schoeman
Vitamins and Hormones
|
November 25, 2010
Dietary effects on incretin hormone secretion
Tongzhi Wu, Christopher K Rayner, Karen Jones, et al.
Drugs
|
August 9, 2007
Pathophysiology and management of diabetic gastropathy: a guide for endocrinologists
Paul Kuo, Christopher K Rayner, Karen L Jones, et al.
Drugs
|
June 6, 2009
Diabetic gastroparesis: diagnosis and management
Jing Ma, Christopher K Rayner, Karen L Jones, et al.
Therapeutics and Clinical Risk Management
|
August 27, 2009
Incretin-based therapies: new treatments for type 2 diabetes in the new millennium
Joan Khoo, Christopher K Rayner, Karen L Jones, et al.
Pharmaceutics
|
August 23, 2020
Enteroendocrine Hormone Secretion and Metabolic Control: Importance of the Region of the Gut Stimulation
Cong Xie, Karen L Jones, Christopher K Rayner, et al.
Page
of 26